The effect of estradiol and progesterone therapy in serum and liver on the lipid profile of
naturally menopausal albino rats of the Wistar strain of different age groups (12, 18 and …

Estrogen replacement therapy (ERT) is claimed to reduce cardiovascular mortality by about
50% in postmenopausal women. This improvement is caused by favorable changes in lipid …

The present study was performed to document factors playing a role in the age-related
increase of serum total cholesterol, triglycerides, and phospholipids in male WISTAR rats. In …

Age and sex influence serum cholesterol levels, but the underlying mechanisms remain
unclear. To investigate further, we measured cholesterol, precursors (surrogate synthesis …

Background: Cardiovascular diseases (CVDs) are the leading cause of women's mortality,
linked to aging and reduced estrogen during menopause. Estrogen replacement therapy …

Introduction The cardiovascular dysfunctions in postmenopausal diabetic women increase
relative to premenopausal women. In this study we evaluated protective effects of selective …

Indian ethnicity by itself is a strong risk factor for development of CAD in Indian
postmenopausal women due to lower HDL levels as compared to Whites and women of …

Estrogen compounds have been described as important brain protectors. This study
investigated the effects of estradiol valerate (EV—0.3 mg/kg) and two concentrations of …

The aim of this study was to determine the effect of administration of estradiol (E 2),
progesterone (P 4), and combination of estradiol and progesterone (EP) in aging female …

In aging liver oxidative stress increases due to the decrease in antioxidant bio-molecules
such as estrogens which can be modified by hormonal replacement therapy (HRT). With this …